Literature DB >> 15979593

Proteolysis of neuronal cytoskeletal proteins by calpain contributes to rat retinal cell death induced by hypoxia.

Yoshiyuki Tamada1, Emi Nakajima, Takeshi Nakajima, Thomas R Shearer, Mitsuyoshi Azuma.   

Abstract

Our previous studies in retina on the mechanism for hypoxia-induced cell death suggested activation of a class of calcium-activated proteases known as calpains. This conclusion was based on data showing proteolysis of a calpain substrate alpha-spectrin, autolysis of activated calpain, and reduction of cell damage by calpain inhibitor SJA6017. Less is known about changes in downstream pathways after calpain activation. Thus, the purpose of the present investigation was to measure proteolysis of neuronal cytoskeletal proteins and apoptotic cell signaling factors during hypoxia-induced retinal cell death. Rat retinas were incubated in RPMI medium with glucose and 95% O2/5% CO2 to supply sufficient oxygen for retinal cell survival. Hypoxia was induced with 95% N2/5% CO2 without glucose. Immunoblotting was used to detect activation of calpain and proteolysis of substrates. Amounts of mRNA for calpain 1 and 2 were determined by quantitative PCR. Twelve times more calpain 2 mRNA than calpain 1 was present in retinas. Activation of calpain 2 and production of a calpain-specific alpha-spectrin breakdown product at 150 kDa were confirmed in hypoxic retinas. Further, pro-caspase-3 at 32 kDa was proteolyzed to a fragment at 30 kDa, tau protein was lost, and p35 was proteolyzed to p25 suggesting prolonged activation of cdk5. SJA6017 partially inhibited the production of these fragments. During hypoxia in rat retinas, calpains may be major proteases causing breakdown of neuronal proteins involved in apoptotic cell death. Calpain inhibitor SJA6017 may have potential for testing as a therapeutic agent against retinal pathologies such those caused by glaucoma, although future studies such as testing in in vivo animal models are required.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15979593     DOI: 10.1016/j.brainres.2005.05.048

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  16 in total

1.  A precise temporal dissection of monosodium glutamate-induced apoptotic events in newborn rat retina in vivo.

Authors:  Viktória Dénes; Mónika Lakk; Nikoletta Czotter; Róbert Gábriel
Journal:  Neurochem Res       Date:  2011-04-22       Impact factor: 3.996

2.  Calpain, not caspase, is the causative protease for hypoxic damage in cultured monkey retinal cells.

Authors:  Emi Nakajima; Katherine B Hammond; Jennifer L Rosales; Thomas R Shearer; Mitsuyoshi Azuma
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-01       Impact factor: 4.799

Review 3.  The role of calcium-activated protease calpain in experimental retinal pathology.

Authors:  M Azuma; T R Shearer
Journal:  Surv Ophthalmol       Date:  2008 Mar-Apr       Impact factor: 6.048

4.  Gel-based protease proteomics for identifying the novel calpain substrates in dopaminergic neuronal cell.

Authors:  Chiho Kim; Nuri Yun; Young Mook Lee; Jae Y Jeong; Jeong Y Baek; Hwa Young Song; Chung Ju; Moussa B H Youdim; Byung K Jin; Won-Ki Kim; Young J Oh
Journal:  J Biol Chem       Date:  2013-11-14       Impact factor: 5.157

5.  Calpain inhibition protected spinal cord motoneurons against 1-methyl-4-phenylpyridinium ion and rotenone.

Authors:  S Samantaray; V H Knaryan; C Le Gal; S K Ray; N L Banik
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

6.  Ischemic stroke injury is mediated by aberrant Cdk5.

Authors:  Douglas A Meyer; Melissa I Torres-Altoro; Zhenjun Tan; Alessandro Tozzi; Massimiliano Di Filippo; Vincent DiNapoli; Florian Plattner; Janice W Kansy; Stanley A Benkovic; Jason D Huber; Diane B Miller; Paul Greengard; Paolo Calabresi; Charles L Rosen; James A Bibb
Journal:  J Neurosci       Date:  2014-06-11       Impact factor: 6.167

Review 7.  Neuroprotection in glaucoma using calpain-1 inhibitors: regional differences in calpain-1 activity in the trabecular meshwork, optic nerve and implications for therapeutics.

Authors:  Bharathi Govindarajan; James Laird; Ronald Sherman; Robert G Salomon; Sanjoy K Bhattacharya
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

8.  Spectrin Breakdown Products (SBDPs) as Potential Biomarkers for Neurodegenerative Diseases.

Authors:  Xiao-Xin Yan; Andreas Jeromin; A Jeromin
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2012-06

Review 9.  Contribution of hypoxia to Alzheimer's disease: is HIF-1alpha a mediator of neurodegeneration?

Authors:  O O Ogunshola; X Antoniou
Journal:  Cell Mol Life Sci       Date:  2009-09-11       Impact factor: 9.261

Review 10.  Review: tauopathy in the retina and optic nerve: does it shadow pathological changes in the brain?

Authors:  Wing-Lau Ho; Yen Leung; Andrea Wing-Ting Tsang; Kwok-Fai So; Kin Chiu; Raymond Chuen-Chung Chang
Journal:  Mol Vis       Date:  2012-11-12       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.